Otsuka Of Japan Reveals Plan To Buy Other Pharmas With IPO Funds
This article was originally published in PharmAsia News
Japan's Otsuka Holdings is telling would-be investors it plans to acquire other pharmaceutical firms with the funds it hopes to garner from an initial public offering. Two sources briefed on the IPO plans said Otsuka also plans to buy health-food businesses and to issue a dividend as soon as it is listed on the stock exchange. CEO Tatsuo Higuchi disclosed the plans in a closed briefing for investors and analysts, the sources said. (Click here for more)
You may also be interested in...
The US FDA tells manufacturers in two recent warning letters to get to the root cause of contamination problems and take a more proactive approach to cleaning and equipment maintenance.
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.